61 related articles for article (PubMed ID: 31964199)
1. Radiation dose-painting with protons vs. photons for head-and-neck cancer.
Håkansson K; Smulders B; Specht L; Zhu M; Friborg J; Rasmussen JH; Bentzen SM; Vogelius IR
Acta Oncol; 2020 May; 59(5):525-533. PubMed ID: 31964199
[No Abstract] [Full Text] [Related]
2. Impact of robust treatment planning on single- and multi-field optimized plans for proton beam therapy of unilateral head and neck target volumes.
Cubillos-Mesías M; Baumann M; Troost EGC; Lohaus F; Löck S; Richter C; Stützer K
Radiat Oncol; 2017 Nov; 12(1):190. PubMed ID: 29183377
[TBL] [Abstract][Full Text] [Related]
3. Biological optimization for hybrid proton-photon radiotherapy.
Li W; Lin Y; Li HH; Shen X; Chen RC; Gao H
Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38759678
[No Abstract] [Full Text] [Related]
4. Feasibility and sensitivity study of helical tomotherapy for dose painting plans.
Deveau MA; Bowen SR; Westerly DC; Jeraj R
Acta Oncol; 2010 Oct; 49(7):991-6. PubMed ID: 20831487
[TBL] [Abstract][Full Text] [Related]
5. Clinical controversies: proton therapy for pediatric tumors.
Merchant TE
Semin Radiat Oncol; 2013 Apr; 23(2):97-108. PubMed ID: 23473686
[TBL] [Abstract][Full Text] [Related]
6. Proton therapy in clinical practice.
Liu H; Chang JY
Chin J Cancer; 2011 May; 30(5):315-26. PubMed ID: 21527064
[TBL] [Abstract][Full Text] [Related]
7. Online daily adaptive proton therapy.
Albertini F; Matter M; Nenoff L; Zhang Y; Lomax A
Br J Radiol; 2020 Mar; 93(1107):20190594. PubMed ID: 31647313
[TBL] [Abstract][Full Text] [Related]
8. Balancing robustness and adaptation rate for proton therapy of lung cancer patients.
Badiu V; Trier Taasti V; Defraene G; van Elmpt W; Sterpin E
Radiother Oncol; 2024 Jul; 196():110290. PubMed ID: 38643807
[TBL] [Abstract][Full Text] [Related]
9. Interim
Garrido-Hernandez G; Henjum H; Winter RM; Alsaker MD; Danielsen S; Boer CG; Ytre-Hauge KS; Redalen KR
Phys Med; 2024 Jun; 123():103404. PubMed ID: 38852365
[TBL] [Abstract][Full Text] [Related]
10. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.
Frank SJ; Blanchard P; Lee JJ; Sturgis EM; Kies MS; Machtay M; Vikram B; Garden AS; Rosenthal DI; Gunn GB; Fuller CD; Hutcheson K; Lai S; Busse PM; Lee NY; Lin A; Foote RL
Semin Radiat Oncol; 2018 Apr; 28(2):108-113. PubMed ID: 29735186
[TBL] [Abstract][Full Text] [Related]
11. The potential benefit of radiotherapy with protons in head and neck cancer with respect to normal tissue sparing: a systematic review of literature.
van de Water TA; Bijl HP; Schilstra C; Pijls-Johannesma M; Langendijk JA
Oncologist; 2011; 16(3):366-77. PubMed ID: 21349950
[TBL] [Abstract][Full Text] [Related]
12. Mitigating Radiotoxicity in the Central Nervous System: Role of Proton Therapy.
Winter SF; Vaios EJ; Shih HA; Grassberger C; Parsons MW; Gardner MM; Ehret F; Kaul D; Boehmerle W; Endres M; Dietrich J
Curr Treat Options Oncol; 2023 Nov; 24(11):1524-1549. PubMed ID: 37728819
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial approach of immuno-proton therapy in cancer: Rationale and potential impact.
Gaikwad U; Bajpai J; Jalali R
Asia Pac J Clin Oncol; 2024 Apr; 20(2):188-197. PubMed ID: 37194387
[TBL] [Abstract][Full Text] [Related]
14. Head and Neck Cancers, Version 1.2015.
Pfister DG; Spencer S; Brizel DM; Burtness B; Busse PM; Caudell JJ; Cmelak AJ; Colevas AD; Dunphy F; Eisele DW; Foote RL; Gilbert J; Gillison ML; Haddad RI; Haughey BH; Hicks WL; Hitchcock YJ; Jimeno A; Kies MS; Lydiatt WM; Maghami E; McCaffrey T; Mell LK; Mittal BB; Pinto HA; Ridge JA; Rodriguez CP; Samant S; Shah JP; Weber RS; Wolf GT; Worden F; Yom SS; McMillian N; Hughes M
J Natl Compr Canc Netw; 2015 Jul; 13(7):847-55; quiz 856. PubMed ID: 26150579
[TBL] [Abstract][Full Text] [Related]
15. Myths and realities of range uncertainty.
Lomax AJ
Br J Radiol; 2020 Mar; 93(1107):20190582. PubMed ID: 31778317
[TBL] [Abstract][Full Text] [Related]
16. Current Status and Future Directions of Proton Therapy for Head and Neck Carcinoma.
Lillo S; Mirandola A; Vai A; Camarda AM; Ronchi S; Bonora M; Ingargiola R; Vischioni B; Orlandi E
Cancers (Basel); 2024 May; 16(11):. PubMed ID: 38893203
[TBL] [Abstract][Full Text] [Related]
17. [Protontherapy : principles, advantages, limitations, indications, perspectives...and some Belgian peculiarities].
Daisne JF; Isebaert S; Geets X; Donnay L; Sterpin E
Rev Med Liege; 2024 May; 79(S1):9-15. PubMed ID: 38778643
[TBL] [Abstract][Full Text] [Related]
18. Dual anti-HER2/EGFR inhibition synergistically increases therapeutic effects and alters tumor oxygenation in HNSCC.
Song PN; Lynch SE; DeMellier CT; Mansur A; Gallegos CA; Wright BD; Hartman YE; Minton LE; Lapi SE; Warram JM; Sorace AG
Sci Rep; 2024 Feb; 14(1):3771. PubMed ID: 38355949
[TBL] [Abstract][Full Text] [Related]
19. Quality of Life and Patient-Reported Outcomes Following Proton Therapy for Oropharyngeal Carcinoma: A Systematic Review.
Yahya N; Manan HA
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190180
[TBL] [Abstract][Full Text] [Related]
20. Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma.
Mendenhall WM; Beitler JJ; Saba NF; Shaha AR; Nuyts S; Strojan P; Bollen H; Cohen O; Smee R; Ng SP; Eisbruch A; Ng WT; Kirwan JM; Ferlito A
Int J Part Ther; 2023; 9(4):243-252. PubMed ID: 37169005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
